The U.S. government has subpoenaed Wyeth in connection with its marketing to doctors of the antidepressant drug Effexor, making it the third drug company in a week to receive a subpoena in a widening federal investigation.
Sheehan, assistant U.S. attorney in Philadelphia, said Wyeth,
Johnson & Johnson and Forest Laboratories
Inc. have been subpoenaed in a probe related to potentially
over-aggressive marketing of psychiatric drugs.
The subpoenas came
from the inspector general for the Office of Personnel Management, which
investigates potential fraud involving the health benefits of about 10
million federal employees and retirees.